Abstract
Introduction
Traditionally, in the critically ill patient, nutrition is provided through enteral as well as parenteral routes The current guidelines of the European Society for Parenteral and Enteral Nutrition (ESPEN) and American Society of Parenteral and Enteral nutrition (ASPEN) recommend use of enteral nutrition over parenteral nutrition in the case of patients undergoing major gastrointestinal surgery for cancer, as it is known to reduce septic morbidity rates [1, 2] . Enteral nutrition may be provided as oral supplements in the form of drink supplements after upper gastrointestinal surgery via an enteral tube into the stomach or small bowel. There are different methods of enteral tube feeding; enteral feeding is usually by nasoenteric or enterostomy tubes [2, 3] . In this study we assessed whether nasojejunal tube placement is superior to feeding jejunostomy.
Methods
Twenty patients comprised ten patients in the feeding jejunostomy group and ten in the nasojejunal feeding group. The median age for feeding jejunostomy patients was 53 years (32-72) and for nasojejunal tube feeding patients was 56 years (32-67). A comparison of groups did not show a difference between the feeding jejunostomy and naso-jejunal feeding group (table 1) .
Route of feeding
For nasojejunal feeding, we introduced a flexible 14 Ch feeding tube through the nose which was positioned in the jejunum at the time of operation. In feeding jejunostomy, a 14F catheter was placed transabdominally into the jejunum during at the end of the procedure as previously described [3] . Both tubes were stabilized -nasojejunal tube at the nostril and feeding jejunostomy catheter at the anterior abdominal wallwith a 3/0 silk suture. The choice of feeding route was based on individual surgeon's preference.
Data collection and analysis
Data were collected using a questionnaire. The type of surgery, operative factors affecting outcome, preoperative nutritional level, pre-operative morbidity, type of feeding and its complications, post-operative morbidity, mortality and period of hospital stay were gathered prospectively during daily patient visits. Primary endpoints were the time to removal of the tube and tube related complications. Secondary end points were complications of tube feeding, surgical morbidity, mortality and length of hospital stay.
Inclusion and Exclusion criteria
All elective upper gastrointestinal surgical procedures in our unit, between October 2011 and October 2012, were studied. Inclusion criteria were; those having oesophagectomy, total and partial gastrectomy, g a s t r o j e j u n o s t o m y, W h i p p l e ' s p a n c r e a t oduodenectomy and palliative triple bypass for inoperable pancreatic cancer. Those excluded were; patients with nasojejunal tubes which were already in place pre-operatively. There were no interventions or deviations from the normal management during this study process.
Collected data were documented in excel sheets and data analysis was performed using the Statistical Package for Social Studies (SPSS version 21.0.0, New York, USA). Data were expressed as either median and range or mean and standard deviation. The test of significance used was a Pearson correlation test. Significance was assigned to a P value of <0.05.
Results
Of twenty two patients available for the study during this period, two were excluded because they had Mortality Four(40 percent) in the feeding jejunostomy group died due to pulmonary aspiration complicating feeding jejunostomy and one (10 percent) died in the nasojejunal feeding group, which was due to disseminated cholangiocarcinoma with obstructive jaundice and multiorgan failure.
Time to removal of the tube Details of the time from placement to removal of the tube are shown in table 3. In the feeding jejunostomy group, 60% of the patients were discharged from hospital with the tube in place and 20% of the tubes were removed after 14 days. The remaining 20% were removed between 10 -14 days. In the nasojejunal feeding group, 60% of the tubes were removed within 10 days of placement.
Complications of tube feeding
Complications that occurred from tube feeding are shown in table 4. In the feeding jejunostomy group, 40% had aspiration pneumonia, 30% had intestinal colics and complications as severe as intra-abdominal abscess formation and peritonitis were found in 20%. Mortality (40%) also found due to these complications. In the nasojejunal feeding group, 50% had nasal tube associated rhino-pharyngitis, 40% had poor compliance and 10% had aspiration pneumonia, resulting in a total complication rate of 100% (including minor tolerable complications) for nasojejunal feeding versus 80% for jejunostomy feeding.
Time to commence feeds
In both groups, time to start feeding after surgery differed according to the patient's condition. Details are shown in table 5. In 80 percent of feeding jejunostomy patients, feeding commenced on the first post-operative day whereas, in the nasojejunal feeding group, feeding commenced between the first and third post-operative day in 60 percent of patients. Feeding through the jejunostomy was discontinued in the third to fourth post operative day due to complications (aspiration pneumonia, intestinal colic, abdominal distention, abscess and peritonitis, obstruction and dislodgementtable 4). Because of the complications of feeding jejunostomy, oral feeding was omitted in one half of feeding jejunostomy patients compared with nasojejunal feeding, where all patients continued to be fed without complication.
Length of hospital stay A majority of patients having feeding jejunostomy stayed in hospital for median of 14 days (10 to 30 days).
In the nasojejunal feeding group median hospital stay was 9 days (3 to 60 days). Only one patient stayed in hospital for 60 days due to the disseminated disease. Hospital stay was significantly affected (p=0.02) by the mode of feeding.
Overall complication rate Table 6 shows the complications, overall, in the feeding jejunostomy and nasojejunal feeding groups. In the feeding jejunostomy group 70 percent of the patients had chest infections, 30 percent had anastomotic leaks and 10 percent were free of complications. In the nasojejunal feeding group 70 percent had chest infections, 10 percent had anastomotic leaks and 20 percent remained free of complications.
Discussion
In this study we compared our experience of nasojejunal tube feeding with feeding jejunostomy after upper gastrointestinal surgery. Both groups were compared according to patient factors, preoperative nutritional level, surgical factors, tube related factors and postoperative morbidity and mortality.
Regarding the common factors, age and gender were not significant in tube feeding outcomes. Malnutrition in patients with cancer has been shown to increase the risk of postoperative complications [4] . In our study both groups had a comparable mean body mass index and serum albumin level.
The primary endpoints in this study were time to removal of the tube and tube related complications. The secondary end points were complications of tube feeding, morbidity, mortality and length of hospital stay. Those fed through a nasojejunal tube received feeds for a short period (7 to 9 days) and most (60 percent) were removed within nine days. By contrast, the majority of feeding jejunostomy patients (80 percent) had their feeding omitted some days after early commencement due to complications that resulted from the tube. Feeding jejunostomy tubes were in place for more than two weeks and most (60 percent) were not removed at the time of hospital discharge. Thus, compared to the feeding jejunostomy group, nasojejunal tube feeding patients were able to have continuous feeding without severe complications.
Review of the literature is supportive of our findings, for example Gerritsen et al showed that feeding jejunostomy patients had greater complications versus nasojejunal feeding patients [5] . In this study we found that after feeding jejunostomy, patients had aspiration pneumonia which led to mortality. Other severe complications were cutaneous and intra-abdominal leakage, peritonitis and intra-abdominal abscess formation. By contrast, complications such as rhino pharyngitis and intolerance of the tube following nasojejunal feeding were better tolerated. Thus, the nasojejunal feeding tube seemed better than the feeding jejunostomy at least in the short term.
Regarding mortality, feeding jejunostomy patients had 40 percent mortality versus 10 percent in the nasojejunal feeding group. In the former, the mortality was due to complications of feeding jejunostomy but in the latter mortality was due to disseminated cancer. Furthermore, the length of hospital stay was reduced in the nasojejunal feeding group compared with feeding jejunostomy group, which, we believe, was due to better patient tolerance, minor complications and early tube removal.
Postoperative chest infections were the most common complication in both groups. In addition, feeding jejunostomy patients had a greater anastomotic leakage where feeding jejunostomy was not a cause for anastomotic leakage, a factor that may have been better controlled if we undertook a randomized study to stratify for factors that influenced anastomotic leakage and surgical procedure. Also, the result of the study may have been improved by evaluation of a greater sample size and, perhaps, performing a multi-centre trial.
In conclusion, after upper gastrointestinal surgery, patients having nasojejunal feeding seemed to fare better than those having a feeding jejunostomy based on continuity and duration of feeding, time to tube removal, tube related morbidity and mortality and, ultimately, length of hospital stay.
